实施BREASTChoice的随机对照试验,这是一个具有个性化风险预测的多层次乳腺重建决策支持工具
Mary C Politi1, Terence M Myckatyn1, Krista Cooksey1
1Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Annals of surgery
|May 27, 2024
概括
BREASTChoice决策工具改善了患者对乳房重建的知识,特别有利于老年人和来自少数种族背景的人. 然而,它并没有显著影响其他关键决策结果.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 医疗保健服务研究 医疗服务研究
背景情况:
- BREASTChoice是一个多层次的决策工具,旨在为患者提供乳房重建选择的教育.
- 它提供个性化的并发症风险估计,并澄清患者的偏好.
- 该工具还向临床医生提供有关患者特定风险和偏好的信息.
研究的目的:
- 将BREASTChoice决策工具整合到电子健康记录中.
- 评估BREASTChoice工具在临床环境中的有效性.
主要方法:
- 进行了一项多站点随机对照试验,对成年女性进行了诊断,诊断出0-III期乳腺癌,接受了乳房切除术.
- 参与者被随机分配到BREASTChoice工具或对照网站.
- 通过调查评估了包括知识,偏好,决策冲突和可用性在内的结果.
主要成果:
- 与对照组相比,使用BREASTChoice的患者表现出更高的知识水平,在老年人和特定种族群体中观察到显著的益处.
- 该工具具有很高的可用性.
- 在决策冲突,治疗偏好匹配或共享决策方面没有明显的改善.
结论:
- 乳腺选择 (BREASTChoice) 是一种创新的工具,可以增强患者对乳腺重建的知识,对老年人和少数群体有显著的优势.
- 需要进一步的研究来解决实施挑战,并评估特别是在高风险患者群体的决策结果.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
252
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
2.6K
相关概念视频
01:21Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
01:12Hazard Ratio
114
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
114